Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin.

Abstract

Four cycles of EP constitute effective therapy and can be offered to patients with good-risk GCT. In patients with intermediate- and poor-risk GCT, clinical trials remain a priority to identify more effective treatment.